ArticleBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz2026
[Assisted suicides in Bavaria from 2020 to 2023-the first results from the multiple cause of death statistics].
Article in Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development, implementation, and evaluation of a registry for the documentation and analysis of assisted suicide in Germany (RegAS) - study protocol.BMC medical ethics · 2026Article
- [Suicides in agriculture: a cross-population analysis based on Bavarian police crime statistics].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAssisted suicide (AS) is permitted in Germany under certain conditions. To date, figures on AS in Germany are only available from Munich. The aim of this study is to collect data on AS cases involving residents of Bavaria, including sociodemographic characteristics, existing medical conditions, and drugs used.
methodsThe retrospective analysis for the years 2020 to 2023 is based on the information provided in the death certificate, which leads to the official cause of death statistics of the Bavarian State Office for Statistics and represents the total of all deceased persons residing in Bavaria.
resultsA total of 316 AS cases were identified in Bavaria. The AS rate increased from 0.1 to 1.3 deaths per 100,000 inhabitants during the study period. In 2023, AS accounted for almost 1 in 10 suicides in Bavaria and for 0.1% of all deaths. Almost two thirds of AS cases were female. Around half were between 65 and 84 years old. Almost a third suffered from neurodegenerative diseases and around a quarter from cancer. In addition, mental illness was documented in 7% of AS cases, with dementia and affective disorders being present in a third of these cases, respectively. AS in neurodegenerative diseases had a low mean age at death of 70.9 years. At 88.6%, thiopental was the most commonly used drug. Chloroquine, propofol, or phenobarbital were used less frequently. DISCUSSION: The number of AS cases in Bavaria is constantly increasing and now accounts for 0.1% of all deaths, which underlines the relevance of the topic for society as a whole. As AS seems to be of particular importance for patients with neurodegenerative and cancer diseases, suicide prevention should focus on these vulnerable groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.